Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
VS12
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
VS10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Uncaria tomentosa extract
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021
Masoprocol
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Dobutamine
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/24/2021
Wogonin
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Kaempferol
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021
Quercetin
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Luteolin
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Genz-667161
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Genz-123346
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Resveratrol
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/23/2021
J08-MUT
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/23/2021
Ethaselen
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
rSIFN-co
Potential treatment - clinical evidence Experimental Antiviral Feb/23/2021
Imiglitazar
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
Montelukast
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/23/2021
Salvianolic acid A
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
PF-03715455
Potential treatment - theoretical effect Experimental Antiviral Feb/23/2021
2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021